| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |